Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization - PubMed (original) (raw)
. 1998 Dec 15;92(12):4758-63.
Affiliations
- PMID: 9845542
Free article
Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization
N Takahashi et al. Blood. 1998.
Free article
Abstract
Chronic myeloid leukemia (CML) is thought to arise from a pluripotent hematopoietic stem cell that has undergone a reciprocal translocation between the BCR gene on chromosome 22 and the ABL proto-oncogene on chromosome 9. This rearrangement results in a shortened chromosome 22, designated the Philadelphia (Ph) chromosome. The Ph chromosome has been found in cells from all hematopoietic lineages except mature T lymphocytes. To examine this issue, we combined fluorescence-activated cell sorting (FACS) and fluorescence in situ hybridization (FISH) to study lineage involvement of mature cells and stem cells in 12 patients with CML in the chronic phase. We found Ph chromosomes in myeloid cells and most B lymphocytes (CD19(+)) but not in mature T cells (CD3(+)) or natural killer (NK) cells (CD3(-)56(+)). Moreover, evidence of BCR/ABL fusion was found in pluripotent stem cells (CD34(+)Thy-1(+)), B-progenitor cells (CD34(+)CD19(+)), T/NK progenitor cells (CD34(+)CD7(+) cells), and T progenitor cells (CD34(+)CD7(+)CD5(+)) with a frequency equal to that in all CD34(+) cells isolated by FACS from bone marrow cells. T lymphocytes showed a marked decrease in Ph+ cells between progenitor cells and mature cells. Moreover, the ratios of Ph+ to Ph- cells in mature T cells and NK cells were below background levels, whereas Ph+ B lymphocytes also decreased during their maturation. These data suggest that Ph+ lymphocytes are eliminated during differentiation. In contrast to FISH of blood and bone marrow, which gives information principally about mature cells, the technique of "sorter FISH (FACS + FISH)" provides a powerful tool to explore the cytogenetic changes in immature cell populations of stem cell diseases based on immunophenotypes. Further clarification of genetic changes in stem cells could be achieved by using sorter FISH with monoclonal antibodies.
Similar articles
- [Progress in laboratory medicine in chronic myeloid leukemia].
Miura A. Miura A. Rinsho Byori. 1998 Dec;46(12):1226-31. Rinsho Byori. 1998. PMID: 9916508 Review. Japanese. - Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature.
Ichinohasama R, Miura I, Takahashi N, Sugawara T, Tamate E, Endoh K, Endoh F, Naganuma H, DeCoteau JF, Griffin JD, Kadin ME, Ooya K. Ichinohasama R, et al. Leukemia. 2000 Jan;14(1):169-82. doi: 10.1038/sj.leu.2401606. Leukemia. 2000. PMID: 10637493 Review. - Simultaneous demonstration of the Philadelphia chromosome in T, B, and myeloid cells.
MacKinney AA Jr, Clark SS, Borcherding W, Fizzotti M, Hong R. MacKinney AA Jr, et al. Am J Hematol. 1993 Sep;44(1):48-52. doi: 10.1002/ajh.2830440110. Am J Hematol. 1993. PMID: 7688179 - Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.
Van den Berg D, Wessman M, Murray L, Tong J, Chen B, Chen S, Simonetti D, King J, Yamasaki G, DiGiusto R, Gearing D, Reading C. Van den Berg D, et al. Blood. 1996 May 15;87(10):4348-57. Blood. 1996. PMID: 8639795
Cited by
- Leukaemia exposure alters the transcriptional profile and function of BCR::ABL1 negative macrophages in the bone marrow niche.
Dawson A, Zarou MM, Prasad B, Bittencourt-Silvestre J, Zerbst D, Himonas E, Hsieh YC, van Loon I, Blanco GR, Ianniciello A, Kerekes Z, Krishnan V, Agarwal P, Almasoudi H, McCluskey L, Hopcroft LEM, Scott MT, Baquero P, Dunn K, Vetrie D, Copland M, Bhatia R, Coffelt SB, Tiong OS, Wheadon H, Zanivan S, Kirschner K, Helgason GV. Dawson A, et al. Nat Commun. 2024 Feb 5;15(1):1090. doi: 10.1038/s41467-024-45471-0. Nat Commun. 2024. PMID: 38316788 Free PMC article. - CAR T-Cell Immunotherapy Treating T-ALL: Challenges and Opportunities.
Ren A, Tong X, Xu N, Zhang T, Zhou F, Zhu H. Ren A, et al. Vaccines (Basel). 2023 Jan 12;11(1):165. doi: 10.3390/vaccines11010165. Vaccines (Basel). 2023. PMID: 36680011 Free PMC article. Review. - Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study.
Rea D, Henry G, Khaznadar Z, Etienne G, Guilhot F, Nicolini F, Guilhot J, Rousselot P, Huguet F, Legros L, Gardembas M, Dubruille V, Guerci-Bresler A, Charbonnier A, Maloisel F, Ianotto JC, Villemagne B, Mahon FX, Moins-Teisserenc H, Dulphy N, Toubert A. Rea D, et al. Haematologica. 2017 Aug;102(8):1368-1377. doi: 10.3324/haematol.2017.165001. Epub 2017 May 18. Haematologica. 2017. PMID: 28522576 Free PMC article. Clinical Trial. - Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein.
Min H, Niu M, Zhang W, Yan J, Li J, Tan X, Li B, Su M, Di B, Yan F. Min H, et al. PLoS One. 2017 Nov 9;12(11):e0187971. doi: 10.1371/journal.pone.0187971. eCollection 2017. PLoS One. 2017. PMID: 29121121 Free PMC article. - Improvement of immune thrombocytopenia with imatinib therapy following chronic myeloid leukemia.
Nakamura Y, Itoh Y, Wakimoto N. Nakamura Y, et al. Int J Hematol. 2023 Apr;117(4):613-617. doi: 10.1007/s12185-022-03492-9. Epub 2022 Nov 14. Int J Hematol. 2023. PMID: 36374396 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous